Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

739
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
739

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimating HIV-1 Viremic Time From Reservoir Sequence Diversity With Uncertainty Quantification.

The Journal of infectious diseases·2026
Same author

Associations of comorbidities, opioid use, and intimate partner violence, with urinary tract infections in pregnancy: implications for prevention and screening.

Journal of osteopathic medicine·2025
Same author

Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy.

Viruses·2025
Same author

In vivo detection of antisense HIV-1 transcripts in untreated and ART-treated individuals.

Life science alliance·2025
Same author

Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy.

bioRxiv : the preprint server for biology·2025
Same author

<i>In vivo</i> detection of HIV-1 antisense transcripts in untreated and ART-treated individuals.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Jul 5, 2025

Visualizing Cell-to-cell Transfer of HIV using Fluorescent Clones of HIV and Live Confocal Microscopy
13:08

Visualizing Cell-to-cell Transfer of HIV using Fluorescent Clones of HIV and Live Confocal Microscopy

Published on: October 7, 2010

16.6K

HIV Expression in Infected T Cell Clones.

Jason W Rausch1, Shadab Parvez1, Sachi Pathak1

  • 1HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.

Viruses
|January 23, 2024
PubMed
Summary

The persistence of HIV-1 infected cells, driven by viral latency and T cell proliferation, is a major hurdle to a cure. Understanding these factors is key to developing strategies for HIV-1 eradication.

Keywords:
HIV reboundT cellclonal expansionhuman immunodeficiency virus (HIV)persistencetranscriptional regulation

More Related Videos

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

15.6K
Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

14.4K

Related Experiment Videos

Last Updated: Jul 5, 2025

Visualizing Cell-to-cell Transfer of HIV using Fluorescent Clones of HIV and Live Confocal Microscopy
13:08

Visualizing Cell-to-cell Transfer of HIV using Fluorescent Clones of HIV and Live Confocal Microscopy

Published on: October 7, 2010

16.6K
A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

15.6K
Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

14.4K

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • Antiretroviral therapy (ART) suppresses HIV-1 replication but does not eliminate the virus.
  • The primary barrier to an HIV-1 cure is the persistence of infected cells harboring replication-competent proviruses.
  • Viral latency and cellular proliferation are key determinants of HIV-1 persistence.

Purpose of the Study:

  • To review the genetic, epigenetic, cellular, and immunological factors influencing HIV-1 transcriptional suppression.
  • To discuss the clonal expansion of HIV-1 reservoir T cells.
  • To explore the interdependencies among these determinants and their implications for HIV-1 persistence.

Main Methods:

  • This review synthesizes existing research on HIV-1 persistence.
  • It examines the mechanisms of viral latency and cellular proliferation in CD4+ T cells.
  • The review discusses the interplay between genetic, epigenetic, cellular, and immunological factors.

Main Results:

  • HIV-1 transcriptional suppression (latency) allows infected cells to evade immune detection.
  • CD4+ T cell proliferation can facilitate HIV-1 propagation without detrimental viral gene expression.
  • Selective pressures on ART favor the expansion of latently infected cell clones.

Conclusions:

  • Incomplete or reversed latency in expanding clones can lead to persistent low-level viremia and rebound after treatment cessation.
  • Understanding the determinants of viral latency and clonal expansion is crucial for developing strategies to eliminate the HIV-1 reservoir.
  • Targeting these persistence mechanisms may offer new avenues for achieving a functional HIV-1 cure.